DNA Methylation as a Biomarker of Exposure and Effect for Particles and Metals

$659,110R01FY2013ESNIH

Harvard School Of Public Health, Boston MA

Investigators

Linked publications & trials

Paper 39108482 Paper 38243142 Paper 36201768 Paper 35500859 Paper 35273649 Paper 34841262 Paper 34717175 Paper 34713707 Paper 34263963 Paper 34252666 Paper 33413450 Paper 32561690 Paper 31636367 Paper 31424985 Paper 30888266 Paper 30822651 Paper 30482937 Paper 30343628 Paper 30216846 Paper 30059941 Paper 29895583 Paper 29888964 Paper 29684737 Paper 29475968 Paper 29263828 Paper 29183624 Paper 29082545 Paper 28953603 Paper 28822065 Paper 28786129 Paper 28734115 Paper 28636816 Paper 28549425 Paper 28486674 Paper 28484038 Paper 28351767 Paper 28289216 Paper 28284819 Paper 27955697 Paper 27927620 Paper 27843151 Paper 27793020 Paper 27690265 Paper 27474937 Paper 27453791 Paper 27391696 Paper 27377873 Paper 27357171 Paper 27351216 Paper 27259001 Paper 27236570 Paper 27219535 Paper 26967543 Paper 26956024 Paper 26733571 Paper 26732377 Paper 26731791 Paper 26724585 Paper 26660284 Paper 26605812 Paper 26546332 Paper 26449931 Paper 26288820 Paper 26272993 Paper 26265203 Paper 26090776 Paper 25769179 Paper 25633388 Paper 25628407 Paper 25582168 Paper 25414198 Paper 25395096 Paper 25238150 Paper 25085564 Paper 25028775 Paper 24884505 Paper 24834832 Paper 24809956 Paper 24755831 Paper 24602767 Paper 24385016 Paper 24257509 Paper 24059437 Paper 23820848 Paper 23710826 Paper 23566092 Paper 23508416 Paper 23468847 Paper 23413885 Paper 23257623 Paper 23232970 Paper 23013112 Paper 22833016 Paper 22798479 Paper 22430802 Paper 22383587 Paper 22237295 Paper 22142875 Paper 22103680 Paper 22100807

Abstract

DESCRIPTION (provided by applicant): We are proposing to renew our ongoing research in Environmental Epigenetics and expand the work to discover and validate biomarkers of exposure to air pollutants and toxic metals. We also propose to develop epigenomic biomarkers of CVD itself and to link these two findings to inform potential biological pathways via which metals and pollutants cause CVD. Our understanding of these mechanisms is currently rudimentary, and often based on high doses in animals. Methylomics offers a promising approach to identification of important pathways in humans at the exposure ranges of interest. The significance of this work lies in the development of genomic biomarkers, a novel approach which utilizes the distinct properties of DNA methylation and the highly developed technologies to measure methylomic changes across the genome due to either CVD or its root causes. Biomarkers of CVD and its risk factors such as air pollution and metals are badly needed, particularly given the aging of the US population, such markers can aid in early diagnosis and prevention of disease progression. Our experienced team of investigators includes expertise in epidemiology, epigenetics, toxicology, metals analysis, bioinformatics, statistics and exposure biology. We are uniquely positioned to use recently developed epigenomic platforms to discover the validate biomarkers of exposure in an innovative longitudinal study of environmental causes of CVD. Our approach utilizes a longitudinal cohort followed for over 48 years, with a rich archive of DNA and a database with extensive CVD phenotyping and longitudinal measures of exposure to air pollutants and toxic metals.

View original record on NIH RePORTER →